Meyer C - Search Results

1

Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine.

Zepp F, Schmitt HJ, Kaufhold A, Schuind A, Knuf M, Habermehl P, Meyer C, Bogaerts H, Slaoui M, Clemens R. Zepp F, et al. Among authors: meyer c. Eur J Pediatr. 1997 Jan;156(1):18-24. doi: 10.1007/s004310050544. Eur J Pediatr. 1997. PMID: 9007484 Clinical Trial.

2

Booster vaccination after neonatal priming with acellular pertussis vaccine.

Knuf M, Schmitt HJ, Jacquet JM, Collard A, Kieninger D, Meyer CU, Siegrist CA, Zepp F. Knuf M, et al. J Pediatr. 2010 Apr;156(4):675-8. doi: 10.1016/j.jpeds.2009.12.019. J Pediatr. 2010. PMID: 20303444 Clinical Trial.

3

Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants.

Zepp F, Schuind A, Meyer C, Sänger R, Kaufhold A, Willems P. Zepp F, et al. Among authors: meyer c. Pediatrics. 2002 Apr;109(4):e58. doi: 10.1542/peds.109.4.e58. Pediatrics. 2002. PMID: 11927731 Clinical Trial.

4

Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children.

Weigl JA, Puppe W, Meyer CU, Berner R, Forster J, Schmitt HJ, Zepp F. Weigl JA, et al. Eur J Pediatr. 2007 Sep;166(9):957-66. doi: 10.1007/s00431-007-0496-x. Epub 2007 Jun 14. Eur J Pediatr. 2007. PMID: 17569085 Free PMC article.

5

Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation.

Meyer CU, Habermehl P, Knuf M, Hoet B, Wolter J, Zepp F. Meyer CU, et al. Hum Vaccin. 2008 May-Jun;4(3):203-9. doi: 10.4161/hv.4.3.5290. Epub 2010 May 11. Hum Vaccin. 2008. PMID: 18382142 Clinical Trial.

6

Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months.

Knuf M, Zepp F, Meyer CU, Habermehl P, Maurer L, Burow HM, Behre U, Janssens M, Willems P, Bisanz H, Vetter V, Schmidt-Ott R. Knuf M, et al. Eur J Pediatr. 2010 Aug;169(8):925-33. doi: 10.1007/s00431-010-1142-6. Epub 2010 Feb 11. Eur J Pediatr. 2010. PMID: 20148263 Clinical Trial.

7

Principles in Immunology for the Design and Development of Vaccines.

Meyer CU, Zepp F. Meyer CU, et al. Methods Mol Biol. 2022;2410:27-56. doi: 10.1007/978-1-0716-1884-4_2. Methods Mol Biol. 2022. PMID: 34914041

8

Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population.

Knuf M, Zepp F, Meyer C, Grzegowski E, Wolter J, Riffelmann M, Wirsing von König CH. Knuf M, et al. Among authors: meyer c. Vaccine. 2006 Mar 15;24(12):2043-8. doi: 10.1016/j.vaccine.2005.11.024. Epub 2005 Nov 28. Vaccine. 2006. PMID: 16356597

9

Cell mediated and antibody immune response to inactivated hepatitis A vaccine.

Schmidtke P, Habermehl P, Knuf M, Meyer CU, Sänger R, Zepp F. Schmidtke P, et al. Among authors: meyer cu. Vaccine. 2005 Oct 25;23(44):5127-32. doi: 10.1016/j.vaccine.2005.06.022. Vaccine. 2005. PMID: 16054733

10

Cell-mediated immunity after pertussis vaccination and after natural infection.

Zepp F, Knuf M, Habermehl P, Schmitt HJ, Meyer C, Clemens R, Slaoui M. Zepp F, et al. Among authors: meyer c. Dev Biol Stand. 1997;89:307-14. Dev Biol Stand. 1997. PMID: 9272364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,518 results

Search Page

Filters